Cargando…
Commentary: Advocating for patient and public involvement and engagement in health economic evaluation
BACKGROUND: Patient and public involvement in health economic evaluation is still relatively rare, compared to other areas of health and social care research. Developing stronger patient and public involvement in health economic evaluation will be important in the future because such evaluations can...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10316557/ https://www.ncbi.nlm.nih.gov/pubmed/37400923 http://dx.doi.org/10.1186/s40900-023-00444-3 |
_version_ | 1785067735178280960 |
---|---|
author | Staniszewska, Sophie Jakab, Ivett Low, Eric Mossman, Jean Posner, Phil Husereau, Don Stephens, Richard Drummond, Michael |
author_facet | Staniszewska, Sophie Jakab, Ivett Low, Eric Mossman, Jean Posner, Phil Husereau, Don Stephens, Richard Drummond, Michael |
author_sort | Staniszewska, Sophie |
collection | PubMed |
description | BACKGROUND: Patient and public involvement in health economic evaluation is still relatively rare, compared to other areas of health and social care research. Developing stronger patient and public involvement in health economic evaluation will be important in the future because such evaluations can impact on the treatments and interventions that patients can access in routine care. MAIN TEXT: The Consolidated Health Economic Evaluation Reporting Standards (CHEERS) is a reporting guideline for authors publishing health economic evaluations. We established an international group of public contributors who were involved in the update of the CHEERS 2022 reporting guidance, ensuring two items (areas of reporting) specifically about public involvement were included. In this commentary we focus on the development of a guide to support public involvement in reporting, a key suggestion made by the CHEERS 2022 Public Reference Group, who advocated for greater public involvement in health economic evaluation. This need for this guide was identified during the development of CHEERS 2022 when it became apparent that the language of health economic evaluation is complex and not always accessible, creating challenges for meaningful public involvement in key deliberation and discussion. We took the first step to more meaningful dialogue by creating a guide that patient organisations could use to support their members to become more involved in discussions about health economic evaluations. CONCLUSIONS: CHEERS 2022 provides a new direction for health economic evaluation, encouraging researchers to undertake and report their public involvement to build the evidence base for practice and may provide some reassurance to the public that their voice has played a part in evidence development. The CHEERS 2022 guide for patient representatives and patient organisations aims to support that endeavour by enabling deliberative discussions among patient organisations and their members. We recognise it is only a first step and further discussion is needed about the best ways to involve public contributors in health economic evaluation. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40900-023-00444-3. |
format | Online Article Text |
id | pubmed-10316557 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-103165572023-07-04 Commentary: Advocating for patient and public involvement and engagement in health economic evaluation Staniszewska, Sophie Jakab, Ivett Low, Eric Mossman, Jean Posner, Phil Husereau, Don Stephens, Richard Drummond, Michael Res Involv Engagem Comment BACKGROUND: Patient and public involvement in health economic evaluation is still relatively rare, compared to other areas of health and social care research. Developing stronger patient and public involvement in health economic evaluation will be important in the future because such evaluations can impact on the treatments and interventions that patients can access in routine care. MAIN TEXT: The Consolidated Health Economic Evaluation Reporting Standards (CHEERS) is a reporting guideline for authors publishing health economic evaluations. We established an international group of public contributors who were involved in the update of the CHEERS 2022 reporting guidance, ensuring two items (areas of reporting) specifically about public involvement were included. In this commentary we focus on the development of a guide to support public involvement in reporting, a key suggestion made by the CHEERS 2022 Public Reference Group, who advocated for greater public involvement in health economic evaluation. This need for this guide was identified during the development of CHEERS 2022 when it became apparent that the language of health economic evaluation is complex and not always accessible, creating challenges for meaningful public involvement in key deliberation and discussion. We took the first step to more meaningful dialogue by creating a guide that patient organisations could use to support their members to become more involved in discussions about health economic evaluations. CONCLUSIONS: CHEERS 2022 provides a new direction for health economic evaluation, encouraging researchers to undertake and report their public involvement to build the evidence base for practice and may provide some reassurance to the public that their voice has played a part in evidence development. The CHEERS 2022 guide for patient representatives and patient organisations aims to support that endeavour by enabling deliberative discussions among patient organisations and their members. We recognise it is only a first step and further discussion is needed about the best ways to involve public contributors in health economic evaluation. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40900-023-00444-3. BioMed Central 2023-07-03 /pmc/articles/PMC10316557/ /pubmed/37400923 http://dx.doi.org/10.1186/s40900-023-00444-3 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Comment Staniszewska, Sophie Jakab, Ivett Low, Eric Mossman, Jean Posner, Phil Husereau, Don Stephens, Richard Drummond, Michael Commentary: Advocating for patient and public involvement and engagement in health economic evaluation |
title | Commentary: Advocating for patient and public involvement and engagement in health economic evaluation |
title_full | Commentary: Advocating for patient and public involvement and engagement in health economic evaluation |
title_fullStr | Commentary: Advocating for patient and public involvement and engagement in health economic evaluation |
title_full_unstemmed | Commentary: Advocating for patient and public involvement and engagement in health economic evaluation |
title_short | Commentary: Advocating for patient and public involvement and engagement in health economic evaluation |
title_sort | commentary: advocating for patient and public involvement and engagement in health economic evaluation |
topic | Comment |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10316557/ https://www.ncbi.nlm.nih.gov/pubmed/37400923 http://dx.doi.org/10.1186/s40900-023-00444-3 |
work_keys_str_mv | AT staniszewskasophie commentaryadvocatingforpatientandpublicinvolvementandengagementinhealtheconomicevaluation AT jakabivett commentaryadvocatingforpatientandpublicinvolvementandengagementinhealtheconomicevaluation AT loweric commentaryadvocatingforpatientandpublicinvolvementandengagementinhealtheconomicevaluation AT mossmanjean commentaryadvocatingforpatientandpublicinvolvementandengagementinhealtheconomicevaluation AT posnerphil commentaryadvocatingforpatientandpublicinvolvementandengagementinhealtheconomicevaluation AT husereaudon commentaryadvocatingforpatientandpublicinvolvementandengagementinhealtheconomicevaluation AT stephensrichard commentaryadvocatingforpatientandpublicinvolvementandengagementinhealtheconomicevaluation AT drummondmichael commentaryadvocatingforpatientandpublicinvolvementandengagementinhealtheconomicevaluation |